Salicylamide/Acetaminophen/Caffeine

水杨酰胺/对乙酰氨基酚/咖啡因

Report date: 2026/04/08 15:42:36

Base Information

Drug NameSalicylamide/Acetaminophen/Caffeine
Drug Alias Name氨咖柳胺
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsCyclooxygenasesAdenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsHeadacheFeverNeuralgia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes SalicylamideAcetaminophenCaffeine
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHeadacheFeverNeuralgia +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A